Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFIBNASDAQ:ICUNASDAQ:NMRDNASDAQ:NMTC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.03+1.3%$0.04$0.03▼$0.22$905K-0.0937,303 shs80,879 shsICUSeaStar Medical$1.27+2.0%$1.55$1.11▼$13.85$12.45M-0.9261,404 shs146,190 shsNMRDNemaura Medical$0.00$0.00▼$0.06$4K0.639,462 shsN/ANMTCNeuroOne Medical Technologies$0.62+1.2%$0.72$0.40▼$1.39$29.15M0.65179,135 shs659,553 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical+1.33%-25.85%-16.02%-35.73%-25.85%ICUSeaStar Medical+1.60%-0.78%-3.05%-30.22%-87.39%NMRDNemaura Medical0.00%0.00%-50.00%0.00%-99.68%NMTCNeuroOne Medical Technologies+0.45%-2.29%+32.51%-42.86%-44.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/AICUSeaStar Medical0.4432 of 5 stars0.05.00.00.01.60.00.0NMRDNemaura MedicalN/AN/AN/AN/AN/AN/AN/AN/ANMTCNeuroOne Medical Technologies2.1721 of 5 stars3.53.00.00.02.51.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus Medical 0.00N/AN/AN/AICUSeaStar Medical 0.00N/AN/AN/ANMRDNemaura Medical 0.00N/AN/AN/ANMTCNeuroOne Medical Technologies 3.00Buy$1.45132.82% UpsideCurrent Analyst Ratings BreakdownLatest NMRD, AFIB, ICU, and NMTC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2025NMTCNeuroOne Medical TechnologiesLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.45(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.13N/AN/A($0.03) per share-1.01ICUSeaStar Medical$135K92.22N/AN/A($6.29) per share-0.20NMRDNemaura Medical$3.02K0.00N/AN/A($0.41) per share0.00NMTCNeuroOne Medical Technologies$5.75M5.13N/AN/A$0.10 per share6.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66MN/A0.00∞N/A-272.74%-311.64%-11.57%N/AICUSeaStar Medical-$26.23M-$7.78N/A∞N/AN/AN/A-627.49%5/14/2025 (Estimated)NMRDNemaura Medical-$14.14M-$0.39N/AN/AN/AN/AN/AN/AN/ANMTCNeuroOne Medical Technologies-$12.32M-$0.26N/A∞N/A-82.17%-270.70%-129.70%5/13/2025 (Estimated)Latest NMRD, AFIB, ICU, and NMTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2025Q4 2024ICUSeaStar Medical-$0.89-$0.90-$0.01-$0.90$0.15 million$0.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus MedicalN/A1.851.57ICUSeaStar MedicalN/A0.540.54NMRDNemaura MedicalN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/A3.642.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%ICUSeaStar Medical1.69%NMRDNemaura Medical4.41%NMTCNeuroOne Medical Technologies16.07%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%ICUSeaStar Medical1.08%NMRDNemaura Medical40.42%NMTCNeuroOne Medical Technologies8.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical34029.78 million28.23 millionOptionableICUSeaStar Medical29.80 million4.37 millionNot OptionableNMRDNemaura Medical4040.35 million24.04 millionNo DataNMTCNeuroOne Medical Technologies2047.39 million28.12 millionOptionableNMRD, AFIB, ICU, and NMTC HeadlinesRecent News About These CompaniesNeuroOne Medical Technologies Corporation: NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical AdvisorMay 12 at 2:48 PM | finanznachrichten.deNeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical AdvisorMay 12 at 8:30 AM | globenewswire.comLadenburg Thalmann Initiates Coverage of NeuroOne Medical Technologies (NMTC) with Buy RecommendationMay 6, 2025 | msn.comNeuroOne Medical Technologies (NASDAQ:NMTC) Now Covered by Analysts at LADENBURG THALM/SH SHMay 6, 2025 | americanbankingnews.comNeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global ConferenceMay 5, 2025 | newsfilecorp.comNeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern TimeMay 1, 2025 | globenewswire.comNeuroOne completes FDA submission for nerve ablation tech to treat facial painApril 24, 2025 | massdevice.comNeuroOne Medical completes FDA submission for OneRF Ablation System RFApril 24, 2025 | markets.businessinsider.comNeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial PainApril 23, 2025 | globenewswire.comNeuroOne Medical Technologies Corporation: NeuroOne Issues Letter to ShareholdersApril 17, 2025 | finanznachrichten.deNeuroOne says tariffs won’t impact business, Zimmer Biomet dealApril 17, 2025 | massdevice.comNeuroOne® Issues Letter to ShareholdersApril 16, 2025 | globenewswire.comNeuroOne Medical’s OneRF technology featured in Fox News storyApril 15, 2025 | markets.businessinsider.comNeuroOne® OneRF® Technology Success Story Featured on Fox NewsApril 14, 2025 | globenewswire.comRonald McClurg Spends US$100k On NeuroOne Medical Technologies StockApril 10, 2025 | finance.yahoo.comDavid A. Rosa Purchases 100,000 Shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC) StockApril 9, 2025 | insidertrades.comNasdaq Dips 5%; NeuroOne Medical Technologies Shares PlummetApril 4, 2025 | benzinga.comNeuroOne prices $8M offeringApril 4, 2025 | massdevice.comNeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common StockApril 4, 2025 | globenewswire.comNeuroOne Medical announces common stock offering, no amount givenApril 4, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumTop Analyst-Rated Healthcare Stocks to Watch NowBy Nathan Reiff | May 11, 2025View Top Analyst-Rated Healthcare Stocks to Watch NowNetflix’s Trillion-Dollar Baby Ambition: Realistic or Ridiculous?By Leo Miller | April 24, 2025View Netflix’s Trillion-Dollar Baby Ambition: Realistic or Ridiculous?3 High-Momentum Gold Stocks Surging on the Metals RallyBy Nathan Reiff | April 30, 2025View 3 High-Momentum Gold Stocks Surging on the Metals RallyNMRD, AFIB, ICU, and NMTC Company DescriptionsAcutus Medical NASDAQ:AFIB$0.03 +0.00 (+1.33%) As of 05/12/2025 03:45 PM EasternAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.SeaStar Medical NASDAQ:ICU$1.27 +0.03 (+2.01%) Closing price 05/12/2025 03:59 PM EasternExtended Trading$1.28 +0.01 (+1.18%) As of 05/12/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.Nemaura Medical NASDAQ:NMRDNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.NeuroOne Medical Technologies NASDAQ:NMTC$0.62 +0.01 (+1.24%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$0.62 0.00 (-0.29%) As of 05/12/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
